| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/30/2009 | EP2104511A2 Alpha b-crystallin as a therapy for inflammation |
| 09/30/2009 | EP2104510A2 Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus |
| 09/30/2009 | EP2104509A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 09/30/2009 | EP2104508A2 Treating acute renal failure with soluble thrombomodulin variants |
| 09/30/2009 | EP2104507A2 T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy |
| 09/30/2009 | EP2104506A2 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2 |
| 09/30/2009 | EP2104499A1 Method and composition for reducing reperfusion injury |
| 09/30/2009 | EP2012811B1 Use of botulinum toxin for alleviating testicular pain |
| 09/30/2009 | EP1789442B1 Muteins of fibroblast growth factor 21 |
| 09/30/2009 | EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 09/30/2009 | EP1509605B1 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1451322B1 Il-21 antagonists |
| 09/30/2009 | EP1404300B1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 09/30/2009 | EP1328297B1 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 09/30/2009 | EP1309627B1 Immunotherapy for chronic myelocytic leukemia with naked anti-nca-90 antibody |
| 09/30/2009 | EP1295604B1 Preventives and remedies for diseases in association with demyelination |
| 09/30/2009 | EP1286689B1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
| 09/30/2009 | EP1240325B1 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 09/30/2009 | EP1141297B1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses |
| 09/30/2009 | EP1037649B1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/30/2009 | EP0983076B1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
| 09/30/2009 | EP0623168B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 09/30/2009 | CN101547704A Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 09/30/2009 | CN101547703A S-nitrosothiol compounds and related derivatives |
| 09/30/2009 | CN101547702A Methods and compositions for oral administration of proteins |
| 09/30/2009 | CN101544697A Fusion protein TT-B7-H4IgV as well as preparation method and application thereof |
| 09/30/2009 | CN101544696A Compound containing pigment epidermal derived factors and preparation method and application thereof |
| 09/30/2009 | CN101544693A Recombined extrasin alpha 1 two-strand body protein and preparation method thereof |
| 09/30/2009 | CN101544690A Vegetable proteins extracted from P.octandra, preparation method and application thereof |
| 09/30/2009 | CN101544686A Application of glycopeptide mixture in preparing adjuvant therapy medicaments of tumor and health food |
| 09/30/2009 | CN101543659A Local vascular delivery system of probucol alone or in combination with sirolimus |
| 09/30/2009 | CN101543626A Medicament for preventing and curing thrombus and preparation method thereof |
| 09/30/2009 | CN101543625A Use of CENP-E binding protein and its coding gene in preparing medicine for suppressing tumor proliferation |
| 09/30/2009 | CN101543624A Purpose of Chilobrachys jingzhao toxin extract-jingzhao toxin-V(JZTX-V) in preparation of drug-breaking medicament |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543478A Boanmycin freeze-dry powder injection and preparation method thereof |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/30/2009 | CN100544765C Process for preparing degradable polyester microsphere wrapping nano insulin |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |
| 09/29/2009 | US7595380 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 09/29/2009 | US7595377 No surface carbohydrate moieties which are susceptible to glycosidase digestion; for implantation into humans; subjecting collagen-containing material to a cellular disruption treatment; digesting with a glycosidase to remove first surface carbohydrate moieties |
| 09/29/2009 | US7595376 Poly zinc finger proteins with improved linkers |
| 09/29/2009 | US7595333 Agent for improving acidosis |
| 09/29/2009 | US7595302 for interfering with the DNA repair of double strand breaks (DSB); novel double-stranded nucleic acid molecules that act as baits and hijack the holocomplex of enzymes responsible of DNA DSB sensing, signaling and/or repair pathways |
| 09/29/2009 | US7595299 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/29/2009 | US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity |
| 09/29/2009 | US7595297 Method of reducing injury to mammalian cells |
| 09/29/2009 | US7595296 contacting the fibroblasts with one or more of the mutant FGF-1 polypeptides; eatly exceed the wild-type polypeptide in ability to stimulate human fibroblasts to proliferate. |
| 09/29/2009 | US7595295 Use of pleiotrophin to promote neurogeneration |
| 09/29/2009 | US7595294 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 09/29/2009 | US7595293 Stable pharmaceutical compositions |
| 09/29/2009 | US7595292 Conjugated biological molecules and their preparation |
| 09/29/2009 | US7595174 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/29/2009 | US7595172 Expressing a precursor polypeptide that has an n-terminal extension cleavable from the polypeptide at a lysine cleavage site, acylating and removing N-terminal extension by enzymatic cleavage |
| 09/29/2009 | US7595155 Multiplex detection probes |
| 09/29/2009 | US7595154 tyrosine kinase; screening for inhibitors of PDGFRA; gastrointestinal stromal tumor (GIST) |
| 09/29/2009 | US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
| 09/29/2009 | US7595047 Compositions and methods for promoting or inhibiting angiogenesis |
| 09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
| 09/29/2009 | US7595040 Deamidated interferon-β |
| 09/29/2009 | US7595038 Methods of treatment using antibodies to follistatin-3 |
| 09/29/2009 | CA2458474C Zwitterionic lipid compound and uses thereof |
| 09/29/2009 | CA2404163C Production of recombinant blood clotting factors in human cell lines |
| 09/29/2009 | CA2334730C Novel cyclosporins |
| 09/29/2009 | CA2322052C Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/29/2009 | CA2319701C Method of promoting erythropoiesis |
| 09/29/2009 | CA2313372C Composition and method for prolonging the useful life of enteral feeding tubes |
| 09/29/2009 | CA2299361C Use of consensus interferon in combination with il-1 receptor antagonist for treatment of patients afflicted with multiple sclerosis |
| 09/29/2009 | CA2293489C Inhibitors of dna immunostimulatory sequence activity |
| 09/29/2009 | CA2274758C Stable glassy state powder formulations |
| 09/29/2009 | CA2273852C Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/24/2009 | WO2009117710A2 Methods of treating inflammation |
| 09/24/2009 | WO2009117676A2 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
| 09/24/2009 | WO2009117672A2 Modification of cellular steady-state membrane potentials in drug resistant bacteria |
| 09/24/2009 | WO2009117622A2 Modified fgf-23 polypeptides and their uses |
| 09/24/2009 | WO2009117616A2 Carbon nanotube compositions and methods of use thereof |
| 09/24/2009 | WO2009117584A2 Anti-inflammatory drug delivery system |
| 09/24/2009 | WO2009117497A1 Delivery of hydrogels as sprays |
| 09/24/2009 | WO2009117480A2 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 09/24/2009 | WO2009117365A2 Vaccine compositons for inducing immune responses against components of drusen |
| 09/24/2009 | WO2009117127A2 Nerve repair with a hydrogel and optional adhesive |
| 09/24/2009 | WO2009117117A1 T cell receptor fusions and conjugates and methods of use there of |
| 09/24/2009 | WO2009117116A2 Heat shock protein gp96 vaccination and methods of using same |
| 09/24/2009 | WO2009117085A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 09/24/2009 | WO2009117035A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/24/2009 | WO2009117018A1 Inhibition of angiogenesis |
| 09/24/2009 | WO2009117004A1 Reagents and methods for use in head and neck cancer diagnosis, classification and therapy |
| 09/24/2009 | WO2009116960A1 Pharmaceutical composition and a method for the production thereof |
| 09/24/2009 | WO2009116944A1 Use of a substance for manufacturing of a medicament for treatment of common cold |
| 09/24/2009 | WO2009116836A2 Agent comprising g-csf for treatment of traumatic peripheral nerve injury and method for treating traumatic peripheral nerve injury with the same |
| 09/24/2009 | WO2009116764A2 Cell migration, cell infiltration, or neovascularization inhibitor through degradation of function of ptk7 protein |